▲ Peaking
Business
Novartis cites cases of previously unknown tumors possibly tied to its SMA gene therapy
Novartis reports nine tumor cases in children treated with Zolgensma, sparking urgent safety scrutiny.
Sma
2 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Sma
This hub groups 2 separate news trends connected to Sma, spanning September 28, 2026 through November 6, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 10 article observations and 10 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Business
🔮 fades ✓
Roche Halts Development of Obesity Drug Candidate
Roche’s sudden halt of its muscle‑sparing obesity antibody reverberates through patients, investors and the biotech pipeline.